Søgning
Søgning på udtrykket 'corona' giver 43 resultater
Dokumenter [5]
Nyt fra tidsskrifterne [+20]
Aktuelle smitsomme sygdomme [18]
Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem.
Ændringer siden version 29:
Indikationer for COVID-19 test er tilføjet.
DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er).
Dette holdningspapir omhandler baggrunden for anbefalingen.
Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale
Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Journal of Medical Virology
16.02.2025
Journal of Medical Virology, Volume 97, Issue 2, February 2025.
PLoS One Infectious Diseases
13.02.2025
Bonso, Mary Rachael Kpordoxah, Gifty Apiung Aninanya . Introduction Ghana faced acute COVID-19 vaccine uptake rejection after the rollout of the initial dose, thus, posing a risk of not reaching herd immunity as necessary to curb the spread of the novel coronavirus disease. Objective In this study, we analysed the impact of perceptions of the COVID-19 infection on COVID-19 vaccine uptake among healthcare workers in the Mampong district of Ghana.
BMJ Open
12.02.2025
. Objectives. People living with HIV (PLWH) were previously shown to have a higher prevalence of non-calcified coronary plaque with discrepant results for coronary stenosis and any plaque prevalence. This systematic review and meta-analysis summarise and estimate pooled effect sizes for observational studies among PLWH using comprehensive coronary CT angiography (CTA). . Design. Preferred Reporting Items for Systematic Review and Meta-analysis reporting guidelines were used. . Data sources.
Clinical Infectious Diseases
8.02.2025
Abstract . Background . Pregnant people are at risk of severe coronavirus disease 2019 (COVID-19) and associated complications. While withholding treatment from pregnant patients is not recommended, little is known about the frequency of antiviral medication use during pregnancy.Methods .
Journal of Medical Virology
20.01.2025
Journal of Medical Virology, Volume 97, Issue 1, January 2025.
Journal of Medical Virology
19.01.2025
Journal of Medical Virology, Volume 97, Issue 1, January 2025.
Journal of Medical Virology
19.01.2025
Journal of Medical Virology, Volume 97, Issue 1, January 2025.
Emerg Microbes Infect
14.01.2025
Volume 14, Issue 1, December 2025 .
American Journal of Tropical Medicine and Hygiene
9.01.2025
. . Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 112 Issue: 1 Pages: 158-160. .
Microbiology and Molecular Biology Reviews
20.12.2024
Microbiology and Molecular Biology Reviews, Ahead of Print.
Clinical Infectious Diseases
19.12.2024
Abstract . Background . The relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral dynamics during acute infection and the development of long coronavirus disease 2019 (COVID-19), or “long COVID,” is largely unknown.Methods . Between October 2021 and February 2022, 7361 people not known to have COVID-19 self-collected nasal swab samples for SARS-CoV-2 reverse-transcription polymerase chain reaction testing every 24–48 hours for 10–14 days.
PLoS One Infectious Diseases
5.12.2024
ero Mazzotta, Matteo Orlandi, Valentina Scheggi, Niccolò Marchionni, Pierluigi Stefàno . Background Septic embolization is a common and potentially life-threatening complication of infective endocarditis (IE), with a prevalence of 22–50%. While acute coronary syndrome secondary to septic embolism is rare, it poses significant risks. Aims This study examines coronary embolism (CE) in left-sided IE, describing clinical characteristics and outcomes.
PLoS One Infectious Diseases
3.12.2024
by Marta Antas, Monika Olech, Anna Szczotka-Bochniarz .
Virulence
2.12.2024
Volume 15, Issue 1, December 2024 .
Journal of Infectious Diseases
30.11.2024
Abstract . Background . With the transition from the coronavirus disease 2019 (COVID-19) pandemic into endemicity, changes in group immunity and the effect of updated XBB.1.5 monovalent vaccine (MonoV) need to be investigated.Methods . A multicenter vaccine cohort was followed for 3 years, and the investigation period was classified into the pre-Omicron, Omicron, and endemic eras. Thirteen sampling points were assessed, including pre- and post-MonoV administration.
Journal of Medical Virology
21.11.2024
Journal of Medical Virology, Volume 96, Issue 11, November 2024.
BMC Infectious Diseases
16.11.2024
. Abstract. Serological diagnostic tests are available that measure antibody levels against SARS-CoV-2 antigens. We utilized the Vaxarray Coronavirus (CoV) seroassay, which measures SARS-CoV-2 IgG antibodies against the full-length spike protein (FLS), receptor binding domain (RBD), and S2 extracellular domain (ECD). Previous serological studies have used reference values that have not been validated and require many samples.
Science Advances
9.11.2024
Science Advances, Volume 10, Issue 45, November 2024.
Journal of Medical Virology
30.10.2024
Journal of Medical Virology, Volume 96, Issue 11, November 2024.
Proceedings of the National Academy of Sciences
30.10.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 44, October 2024.
Aktuelle smitsomme sygdomme [18]
Aktuelle smitsomme sygdomme [18]
Medscape Infectious Diseases
5.10.2024
How should doctors and patients approach SARS-CoV-2 testing when the prevalence of acute respiratory diseases is high? . Medscape Medical News
ProMED
14.02.2025
la - 9. . [Byline: Carla P. Gomez] . . -- . Communicated by: . ProMED . via . ProMED-MBDS . [The following is the abstract from a study on the resurgence of. dengue in the Philippines by Interior et al, published in 2024: . . Abstract . -------- . 'The coronavirus disease 2019 (COVID-19) pandemic has significantly. influenced the epidemiological landscape of various infectious. diseases such as dengue. Dengue is an endemic disease in the.
ProMED
10.02.2025
. . .
CORONAVIRUS DISEASE 2019 UPDATE (04): USA, CDC, VACCINE LOWERED. MORBIDITY/MORTALITY. ***********************************************************************************. A ProMED-mail post.
www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases.
www.isid.org . Date: Fri 7 Feb 2025 . Source: CIDRAP (Center for Infectious Disease Research & Policy). [edited] .
ProMED
9.02.2025
. . .
CORONAVIRUS DISEASE 2019 UPDATE (03): BOLIVIA, BRAZIL, USA (OHIO). *****************************************************************. A ProMED-mail post.
www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases.
www.isid.org . In this update: . [1] Bolivia: mask mandates for schoolchildren; Brazil: COVID-19. deaths . [2] USA (Ohio): COVID-19 cases rebound . . ****** .
ECDC Communicable Disease Threats Report
8.02.2025
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 February and includes updates on Mpox, Shigella sonnei, chikungunya, SARS-CoV-2, Ebola, yellow fever, avian influenza, Middle East respiratory syndrome coronavirus (MERS-CoV) and an overview of respiratory virus epidemiology in the EU/EEA.
ECDC COVID-19 updates
7.02.2025
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 February and includes updates on Mpox, Shigella sonnei, chikungunya, SARS-CoV-2, Ebola, yellow fever, avian influenza, Middle East respiratory syndrome coronavirus (MERS-CoV) and an overview of respiratory virus epidemiology in the EU/EEA.
ProMED
3.02.2025
RSV do not need hospitalization. Those who are. hospitalized may require oxygen, intubation, and/or mechanical. ventilation, and they usually improve with supportive care and are. discharged ina few days. Influenza and respiratory syncytial viruses. plus coronaviruses are usually prevalent during the winter season,. when low temperatures and the presence of families in closed indoor. spaces favors community spread of these viruses through droplet. infection. - Mod.MM . ProMED map:.
ProMED
31.01.2025
ved poliovirus. type 2, and this might suggest that the virus affecting the 20-year. aged man travelling from Hungary might be from an OPV. It appears that. the rates of polio vaccination in the USA have declined in recent. years and even before the novel coronavirus disease 2019 (COVID-19). pandemic to below 95% coverage, and with the burdens the COVID-19. pandemic has thrown on the healthcare service it seems that the. vaccination rates are in decline, threatening in a potential outbreak,.
ProMED
31.01.2025
y has mucus and lasts longer than 3 weeks can be. caused by a range of other issues, including TB. Please speak to your. GP if you think you could be at risk.' . . TB is the world's leading cause of death from a single infectious. agent, having surpassed coronavirus (COVID-19). It is a bacterial. infection that most frequently affects the lungs, which is when it is. infectious. . Symptoms of TB include: . - A cough that lasts more than 3 weeks . - High temperature . - Night sweats . - Loss of appetite .
ProMED
13.01.2025
Institute has not yet issued an official. press release that verifies or negates the existence of such a. variant. . [Byline: Nisreen bin Ibrahim] . . -- . Communicated by: . ProMED . via . ProMED-MENA . [Influenza and respiratory syncytial viruses plus coronaviruses are. usually prevalent during the winter season, when low temperatures and. the presence of families in closed indoor spaces favor community. spread of these viruses through droplet infection. From the newswire.
ECDC Communicable Disease Threats Report
11.01.2025
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4 - 10 January 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, measles, mpox clades I and II, Middle East respiratory syndrome coronavirus (MERS-CoV), respiratory viral infections in China, and avian influenza A(H5N1).
Eurosurveillance latest updates
11.01.2025
. Background. The first Corona Monitoring Nationwide (RKI-SOEP) study (October 2020−February 2021) found a low pre-vaccine SARS-CoV-2 antibody seroprevalence (2.1%) in the German adult population (≥ 18 years). . . Aim.
Eurosurveillance latest updates
26.10.2024
im. To assess whether the population has reverted to pre-pandemic contact behaviour and how this would affect transmission potential of a newly emerging pathogen. . . Methods. We compared two studies on contact behaviour in the Netherlands: the PIENTER Corona study, conducted during and after the pandemic (held every 2–6 months from April 2020) and the PIENTER3 study (2016–17, as pre-pandemic baseline).
ECDC Communicable Disease Threats Report
8.06.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 June 2024 and includes updates on SARS-CoV-2 variant classification, cholera, out-of-season increase in norovirus, seasonal surveillance on West Nile virus infections, Middle East respiratory syndrome coronavirus (MERS-CoV), influenza A(H5N2), Oropouche virus disease, and an overview of respiratory virus epidemiology in the EU/EEA.
ECDC COVID-19 updates
5.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 March - 6 April 2024 and includes updates on SARS-CoV-2, cholera, avian influenza A(H5N1), swine influenza A(H1N2) and Middle East respiratory syndrome coronavirus (MERS-CoV).
ECDC COVID-19 updates
15.03.2024
This protocol describes the common methodology to be applied to established health data registries across seven participating EU/EEA Member States to estimate vaccine effectiveness for Coronavirus disease 2019 (COVID-19) in children and adolescents aged 5-17 years old.
ECDC COVID-19 updates
8.03.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 3-9 March 2024 and includes updates on SARS-CoV-2 variant classification, sexually transmitted infections, Psittacosis cases, product safety recall of InterPharma Sodium Chloride 0.9% 30ml linked to Ralstonia pickettii contamination, cholera and Middle East respiratory syndrome coronavirus (MERS-CoV).
Eurosurveillance latest updates
8.03.2024
. Background. Model projections of coronavirus disease 2019 (COVID-19) incidence help policymakers about decisions to implement or lift control measures. During the pandemic, policymakers in the Netherlands were informed on a weekly basis with short-term projections of COVID-19 intensive care unit (ICU) admissions. . . Aim. We aimed at developing a model on ICU admissions and updating a procedure for informing policymakers. . . Method.